Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey

BACKGROUND: People with Down syndrome (DS) are one of the highest risk groups for mortality associated with COVID-19, but outcomes may differ across countries due to different co-morbidity profiles, exposures, and societal practices, which could have implications for disease management. This study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinku, Halder, Hüls, Anke, Feany, Patrick T, Baumer, Nicole, Dierssen, Mara, Bargagna, Stefania, Costa, Alberto CS, Chicoine, Brian A, Rebillat, Anne-Sophie, Sgandurra, Giuseppina, Valentini, Diletta, Rohrer, R Tilman, Levin, Johannes, Lakhanpaul, Monica, Carfì, Angelo, Sherman, Stephanie L, Strydom, Andre, Ghosh, Sujay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Global Health 2022
Materias:
Research Theme 1: COVID-19 Pandemic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356581/
https://www.ncbi.nlm.nih.gov/pubmed/35932238
http://dx.doi.org/10.7189/jogh.12.05035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356581/
https://www.ncbi.nlm.nih.gov/pubmed/35932238
http://dx.doi.org/10.7189/jogh.12.05035

Ejemplares similares